STERIS Announces Outcome of Ethylene Oxide Trial
(NYSE:STE), DUBLIN, IRELAND, Jan. 21, 2025 (GLOBE NEWSWIRE) — STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced that a jury trial that had been ongoing since December 4, 2024, against Isomedix Operations, Inc. (“Isomedix”), a subsidiary of the Company, ended in a mistrial on January 17, 2025. The case is pending in the […]